Gf Fund Management »

Aclaris Therapeutics shares owned by Gf Fund Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Gf Fund Management from 13F filings

Historical chart of Gf Fund Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Gf Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Gf Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.1k 2.4k 3.75
2025-12-31 $6.4k 2.1k 3.01

More positions owned by Gf Fund Management

NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOG)
Sandisk Corp Common Stock (SNDK)
Tower Semiconductor Common Stock (TSEM)
Lumentum Holdings Common Stock (LITE)
Tesla Common Stock (TSLA)
Broadcom Common Stock (AVGO)
Micron Technology Common Stock (MU)
Meta Platforms Common Stock (META)
Walmart Common Stock (WMT)
Lam Research Corp Common Stock (LRCX)
ASML Holding NV NY Reg Shrs (ASML)

View all positions for Gf Fund Management

Top funds holding Aclaris Therapeutics

BML Capital Management
Deep Track Capital
BlackRock
RA Capital Management
Vivo Capital
Vanguard Group
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Decheng Capital
Adage Capital Partners GP
Balyasny Asset Management
Citadel Advisors
Morgan Stanley
Geode Capital Management

View all funds holding Aclaris Therapeutics